ESPE Abstracts (2023) 97 FC10.5

ESPE2023 Free Communications Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders (6 abstracts)

MCM4 deficiency causing Natural Killer and Glucocorticoid Deficiency with DNA repair defect (AR-NKGCD) - a large cases series from the Irish Traveller population

Anna Fedorczak 1,2 , Claire Reynolds 2 , Eric Somers 2 , Sally Ann Lynch 3 , Ronan Leahy 4 & Susan M O’Connell 2,5


1Department of Endocrinology and Metabolic Diseases, Polish Mothers Memorial Hospital – Research Institute, Łódź, Poland. 2Department of Diabetes and Endocrinology, Children’s Health Ireland at Crumlin, Dublin, Ireland. 3Department of Clinical Genetics, Children’s Health Ireland at Crumlin, Dublin, Ireland. 4Department of Immunology, Children’s Health Ireland at Crumlin, Dublin, Ireland. 5Department of Paediatrics, Royal College of Surgeons of Ireland, Dublin, Ireland


A new condition, unique to Irish Travellers, was first described clinically as autosomal recessive natural killer and glucocorticoid deficiency (AR-NKGCD) ORPHA:75391 in 2008 and was attributed to recessive founder variant in MCM4/PRKDC gene in 2012. Irish Travellers are an indigenous endogamous population numbering ~40,000 in the Republic of Ireland. AR-NKGCD is characterised by short stature, glucocorticoid and natural killer cell deficiency and is a disorder of DNA repair. Since first described, through monitoring cases our knowledge and experience of the condition has grown as more cases have been confirmed.

Objectives: To review the clinical presentation, diagnostic workup, and outcomes of known patients with AR-NKGCD attending our centre over the past 10 years. We compiled data from available medical, laboratory, genetic and radiology records on patients attending paediatric endocrinology and immunology services.

Results: Sequencing analysis of intron 1 of the MCM4/PRKDC gene in all patients (n=15) revealed the known homozygous variant c71-2A>G p.(Phe24Argfs). Those children for whom data was available (n=7), were all small for gestational age, birth weight between 0.4th-2nd centiles. Further endocrine data are outlined in Table 1.

Table 1
Clinical characteristic *n= (%) Description
Short stature 14 (93%) 93% < 9th centile 60% < 2nd centile
Low weight 12 (80%) 80% < 9th centile 60% < 2nd centile
Bone age delay 7 (100%) median delay 2 years
Low morning cortisol (< 100nmol/L) 7 (50%) at diagnosis
Raised adrenocorticotropic hormone (ACTH) 10 (83%) at diagnosis
*n= number of patients where data on that variable was available

Most children (n=14) had mild dysmorphic features. Feeding difficulties, failure to thrive (n=14) and recurrent infections such as respiratory tract (n=8) and herpes simplex labialis (n=6), were observed in infancy and young childhood. Tiredness (n=5), hyperpigmentation (n=8) and mild development delay (n=4) were also observed. All 15 had severe NK cell deficiency (NK cells represented just 0.1-4% of the peripheral blood lymphocytes). Nine patients (60%) required corticosteroid replacement (hydrocortisone doses range 9-15mg/m2), in others only emergency treatment was recommended. Mineralocorticoid secretion was not impaired. A serious adrenal crisis following infection occurred in two patients. Two patients developed haemophagocytic lymphohistiocytosis (HLH), one of which died.

Conclusions AR-NKGCD is a rare disorder affecting children from the Irish Traveller population with a variable phenotype. They have an increased risk of primary adrenal insufficiency, adrenal crisis, infection, malignancies and premature death. Input from endocrinology and immunology specialists is required.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.